Physician

David S Greenstein, M.D.

According to 2025 Medicare claims, David Greenstein, M.D. (NPI: 1205931789) practices dermatology in the Cambridge-Newton-Framingham, MA market, with the plurality of this provider's patient population coming from Essex, MA. This provider's primary affiliated billing organization is NORTHEAST DERMATOLOGY ASSOCIATES, PC (NPI: 1104921162; TIN: 043138013) and primary practice location at 01915-1665.

Greenstein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,486 traditional Medicare patients, billed 15,336 HCPCS/CPT codes, and received $881,873 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 2,336 prescription claims across 935 beneficiaries totaling $2,753,287 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 508 records totaling $382,641. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $451,924 to $881,873. Similarly, Part D prescription costs have moved sharply higher in recent years, from $473,136 to $2,753,287. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,142	10,169	$451,924
2016	2,334	11,845	$542,831
2017	2,470	14,721	$608,950
2018	2,934	17,591	$746,102
2019	2,357	12,044	$558,272
2020	2,047	10,745	$514,387
2021	2,222	11,998	$724,637
2022	2,428	14,414	$882,911
2023	2,524	14,690	$857,375
2024	2,486	15,336	$881,873

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	396	946	$473,136
2016	470	1,134	$476,411
2017	547	1,342	$739,871
2018	697	1,600	$880,483
2019	738	1,824	$811,813
2020	715	1,862	$948,292
2021	750	1,837	$1,465,515
2022	836	2,013	$2,025,142
2023	876	2,261	$2,625,382
2024	935	2,336	$2,753,287

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	301	355	$82
11102	Biopsy of related skin growth, first growth	644	731	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,836	2,458	$62
17000	Destruction of precancer skin growth, 1 growth	954	1,314	$41
17003	Destruction of precancer skin growth, 2-14 growths	701	3,147	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Skyrizi Pen	Risankizumab-Rzaa	21	1,596	$412,494
Taltz Autoinjector	Ixekizumab	52	1,680	$404,171
Dupixent Pen	Dupilumab	93	2,576	$349,040
Humira(Cf) Pen	Adalimumab	41	1,148	$274,206
Stelara	Ustekinumab	11	868	$213,016

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	338	$105,559	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	170	$277,082	Incyte Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David S. Greenstein, M.D.?

Tedicare shows public-source Medicare data for David S. Greenstein, M.D. (NPI 1205931789), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David S. Greenstein, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David S. Greenstein, M.D.?

David S. Greenstein, M.D. is linked to NORTHEAST DERMATOLOGY ASSOCIATES, PC (billing NPI 1104921162) in the available physician profile data.

Does David S. Greenstein, M.D. have Open Payments data?

David S. Greenstein, M.D. has 508 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.